NEWBURY PHARMACEUTICALS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.99 SEK | -4.17% |
|
-0.99% | -2.61% |
| Apr. 10 | Newbury Pharmaceuticals AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 | CI |
| Feb. 22 | Newbury Pharmaceuticals Secures SEK9 Million Sales Order | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Newbury Pharmaceuticals AB is a Sweden-based pharmaceutical company for specialty prescription drugs. The Companyâs existing portfolio is focused on the Scandinavian market and consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology.
Sector
Drug Retailers
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.61% | 6.84M | |
| -11.84% | 8.59B | |
| +29.79% | 1.3B | |
| -11.35% | 356M | |
| -0.21% | 270M | |
| +12.22% | 231M | |
| -9.17% | 87.37M | |
| -45.50% | 84.03M | |
| +28.94% | 62.79M |
- Stock Market
- Equities
- NEWBRY Stock
- News Newbury Pharmaceuticals AB
- Newbury Pharmaceuticals Secures SEK9 Million Sales Order
